A multicenter effort to identify driver mutations and employ targeted therapy in patients with lung adenocarcinomas:The Lung Cancer Mutation Consortium(LCMC). J ClinOncol,2013(suppl。Updated overall survival results from a randomized phase Ⅲ trial comparin ......